Medicare Coverage and Patient Out-of-Pocket Costs for Cardiovascular-Kidney-Metabolic Medications

Grant M Young; Kannu Bansal; Ralph J Riello 3rd; Katherine A A Clark; Sanket S Dhruva; Kamil F Faridi; Nihar R Desai

doi:10.1001/jamanetworkopen.2024.12437

Medicare Coverage and Patient Out-of-Pocket Costs for Cardiovascular-Kidney-Metabolic Medications

JAMA Netw Open. 2024 May 1;7(5):e2412437. doi: 10.1001/jamanetworkopen.2024.12437.

Authors

Grant M Young¹, Kannu Bansal², Ralph J Riello 3rd¹, Katherine A A Clark¹, Sanket S Dhruva³, Kamil F Faridi¹, Nihar R Desai¹

Affiliations

¹ Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
² Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts.
³ Section of Cardiology, Department of Medicine, University of California San Francisco School of Medicine, San Francisco.

No abstract available

Plain language summary

This cross-sectional study evaluates the association between Medicare coverage and patient out-of-pocket costs for cardiovascular-kidney-metabolic medications.

MeSH terms

Aged
Cardiovascular Agents / economics
Cardiovascular Agents / therapeutic use
Cardiovascular Diseases / drug therapy
Cardiovascular Diseases / economics
Female
Health Expenditures* / statistics & numerical data
Humans
Insurance Coverage / economics
Insurance Coverage / statistics & numerical data
Male
Medicare* / economics
United States